096240 — Creverse Balance Sheet
0.000.00%
- KR₩122bn
- KR₩160bn
- KR₩228bn
- 64
- 72
- 53
- 72
Annual balance sheet for Creverse, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 54,533 | 57,283 | 33,387 | 26,821 | 11,721 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 17,030 | 14,098 | 15,490 | 16,043 | 16,635 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 80,626 | 83,300 | 60,463 | 55,044 | 42,661 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 81,099 | 93,409 | 79,203 | 75,699 | 71,960 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 209,615 | 229,861 | 224,150 | 215,848 | 198,414 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 77,500 | 80,643 | 109,055 | 108,909 | 131,497 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 129,175 | 146,857 | 178,888 | 171,906 | 158,156 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 80,441 | 83,004 | 45,262 | 43,942 | 40,258 |
Total Liabilities & Shareholders' Equity | 209,615 | 229,861 | 224,150 | 215,848 | 198,414 |
Total Common Shares Outstanding |